Research paper shows screening for lung cancer dramatically increases early-stage detection, helping to save lives
A new research paper in Nature Medicine shows screening for lung cancer dramatically increases early-stage detection, particularly in socioeconomically deprived areas, helping to save lives. Between April 2019 and March […]
Opdivo® (nivolumab) with chemotherapy before surgery then alone after surgery recommended for use on the NHS when treating adult patients with resectable NSCLC
Nivolumab with chemotherapy before surgery (neoadjuvant) then alone after surgery (adjuvant) has been recommended by the National Institute for Health and Care Excellence (NICE) to treat adult patients with resectable […]
LCNUK Conference 2026!
The LCNUK Annual Conference returns to Glasgow on Thursday 18 – Friday 19 June 2026 at the Hilton Hotel. Join lung cancer nurses and navigators from across the UK for […]
NHS launches trailblazing AI and robot pilot to spot lung cancer sooner alongside screening programme set to tackle cancer inequalities
Patients facing suspected lung cancer could get answers sooner under a new NHS pilot using artificial intelligence and robotic technology to help doctors reach hard-to-detect cancers earlier, with fewer invasive tests. The new […]
Lung Cancer Study Day
Join us on the 24th March 2026 for the Lung Cancer Study Day. This event is Hybrid Overview This multidisciplinary educational event brings together renowned healthcare professionals to explore the […]
Shorter radiotherapy treatments could improve quality of life for patients with advanced lung cancer
The effectiveness of shorter radiotherapy treatments in improving the quality of life for terminally ill lung cancer patients is being explored by University Hospitals Coventry and Warwickshire (UHCW) NHS Trust. […]
Ion robotic-assisted bronchoscopy could enable early lung cancer diagnosis, UK-first study finds
A UK-first study, carried out at Royal Brompton and St Bartholomew’s hospitals, has demonstrated that clinicians can safely and effectively reach and biopsy small nodules in difficult-to-access areas of the […]
UHNM researchers develop groundbreaking blood test for lung cancer
Researchers at University Hospitals of North Midlands NHS Trust (UHNM) have developed a pioneering blood test that could change the way cancer is detected and monitored. The study, published in […]
RYBREVANT®▼(amivantamab) in combination with carboplatin and pemetrexed is accepted for use within NHS Scotland as a first-line treatment for adult patients with advanced non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) exon 20 insertion mutations
Johnson & Johnson welcomes the decision made this week by the Scottish Medicines Consortium (SMC) to accept RYBREVANT®▼ (amivantamab) in combination with carboplatin and pemetrexed for use within NHS Scotland […]
New service speeds up lung cancer diagnosis
Barking, Havering and Redbridge University Hospitals NHS Trust has launched a new thoracoscopy service to help diagnose lung cancer quicker. The procedure investigates unexplained fluid (pleural effusions) between the chest […]
